<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//FR">
<HTML>
<HEAD>
 <LINK HRef="../CSS/ggrcm.css"   Rel="stylesheet" Type="text/css">
 <META name="description" content="M&eacute;dicaments &agrave; base de ibritumomab tiuxetan (biosynthetisch)">
 <META name="keywords" content="Centre Belge d'Information Pharmacoth&eacute;rapeutique; ibritumomab tiuxetan (biosynthetisch)">
 <TITLE>M&eacute;dicaments &agrave; base de Ibuprof&egrave;ne</TITLE>
</HEAD>

<BODY bgcolor="#FFFFFF" LeftMargin="0" RightMargin="0" TopMargin="0" BottomMargin="0" MarginWidth="0" MarginHeight="0">
  <A Name="TopOfPage"></A>

  <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
   <TR> 
    <TD Width="10">&nbsp;</TD>
    <TD Width="30%"><A HRef="../HeaderTxt/LeCBIP.htm">Le C.B.I.P.</A></TD>
    <TD Width="30%"><A HRef="../HeaderTxt/NousContacter.htm">Nous contacter</A></TD>
    <TD Width="30%"><A HRef="../HeaderTxt/Liens.htm">Sites Int&eacute;ressantes</A></TD>
   </TR> 
   <TR> 
    <TD Width="10">&nbsp;</TD>
    <TD Width="30%" Class="footer">Bon &agrave; savoir</TD>
    <TD Width="30%"><A HRef="../Index.htm"><B>Le R&eacute;pertoire</B></A></TD>
    <TD Width="30%" Class="footer">Folia</TD>
   </TR> 
   <TR> 
    <TD ColSpan="4"><HR></TD>
   </TR> 
  </TABLE> 


  <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="10">
   <TR>
    <TD>
     <H1>M&eacute;dicaments &agrave; base de <FONT Color="red">Ibuprof&egrave;ne</FONT></H1>
     <TABLE Width="100%" Border="0" CellPadding="5" CellSpacing="10">
      <TR>
       <TD vAlign="top" Width="33%">
         <P><FONT CLASS="Text">1. Syst&egrave;me cardio-vasculaire<BR>1.15. M&eacute;dicaments pour stimuler la fermeture du canal art&eacute;riel<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_AO.htm">1.15.1. Ibuprof&egrave;ne</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_AO.htm#MP_04075">-Pedea</A> [<FONT class="footer">ibuprof&egrave;ne</FONT>]<BR>
         <P><FONT CLASS="Text">9. Pathologies ost&eacute;o-articulaires<BR>9.1. Anti-inflammatoires non st&eacute;ro&iuml;diens<BR>9.1.1. AINS &agrave; usage syst&eacute;mique<BR>9.1.1.2. D&eacute;riv&eacute;s arylpropioniques<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_IAAB.htm">9.1.1.2.2. Ibuprof&egrave;ne</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_IAAB.htm#MP_00883">-Brufen</A> [<FONT class="footer">ibuprof&egrave;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IAAB.htm#MP_00884">-Buprophar</A> [<FONT class="footer">ibuprof&egrave;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IAAB.htm#MP_00886">-Ibumed</A> [<FONT class="footer">ibuprof&egrave;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IAAB.htm#MP_00887">-Ibuprofen Teva</A> [<FONT class="footer">ibuprof&egrave;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IAAB.htm#MP_00888">-Ibuprofen EG</A> [<FONT class="footer">ibuprof&egrave;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IAAB.htm#MP_00889">-Ibuprofen Sandoz</A> [<FONT class="footer">ibuprof&egrave;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IAAB.htm#MP_00892">-Malafene</A> [<FONT class="footer">ibuprof&egrave;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IAAB.htm#MP_00894">-Nurofen</A> [<FONT class="footer">ibuprof&egrave;ne</FONT>]<BR>
       </TD>
       <TD vAlign="top" Width="33%">
         <A Class="MP_INMP" HREF="../MPG/MPG_IAAB.htm#MP_02550">-Spidifen</A> [<FONT class="footer">ibuprof&egrave;ne arginine</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IAAB.htm#MP_02777">-Optalidon Nouvelle Formule</A> [<FONT class="footer">ibuprof&egrave;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IAAB.htm#MP_02951">-Perdofemina</A> [<FONT class="footer">ibuprof&egrave;ne lysine</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IAAB.htm#MP_02952">-Perdophen</A> [<FONT class="footer">ibuprof&egrave;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IAAB.htm#MP_05812">-Ibuprofen Mylan Pharma</A> [<FONT class="footer">ibuprof&egrave;ne lysine</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IAAB.htm#MP_05849">-Perdotensio</A> [<FONT class="footer">ibuprof&egrave;ne lysine</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IAAB.htm#MP_05931">-Ibuprofen Actavis</A> [<FONT class="footer">ibuprof&egrave;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IAAB.htm#MP_06055">-Ifenin</A> [<FONT class="footer">ibuprof&egrave;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IAAB.htm#MP_06066">-Ibucaps</A> [<FONT class="footer">ibuprof&egrave;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IAAB.htm#MP_06067">-Ibuprofen Mylan</A> [<FONT class="footer">ibuprof&egrave;ne lysine</FONT>]<BR>
         <P><FONT CLASS="Text">9. Pathologies ost&eacute;o-articulaires<BR>9.1. Anti-inflammatoires non st&eacute;ro&iuml;diens<BR>9.1.2. Anti-inflammatoires &agrave; usage local<BR>9.1.2.1. AINS &agrave; usage local<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_IABA.htm">9.1.2.1.1. *</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_IABA.htm#MP_02101">-Extrapan</A> [<FONT class="footer">ibuprof&egrave;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IABA.htm#MP_02107">-Ibuprofen Teva</A> [<FONT class="footer">ibuprof&egrave;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IABA.htm#MP_02108">-Ibutop</A> [<FONT class="footer">ibuprof&egrave;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_IABA.htm#MP_02791">-Ibuprofen Kela</A> [<FONT class="footer">ibuprof&egrave;ne</FONT>]<BR>
       </TD>
      </TR>
     </TABLE>
<P Class="datum">
 <A Href="#TopOfPage">
 <IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A>&nbsp;
</P>

    </TD>
   </TR>
  </TABLE>
 <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="10">
  <TR>
   <TD Align="center">
    <HR WIDTH="90%" SIZE="1" COLOR="#008000" NOSHADE>
    <SPAN Class="footer">
 Centre Belge d 'Information Pharmacoth&eacute;rapeutique (C.B.I.P. asbl) <BR>
 c/o Heymans Instituut, De Pintelaan 185, 9000 Gent<BR>
 </SPAN>
 <A HRef="" Target="_top" Class="footer_link"><font color="#0000FF"></font></A> -
 <A HRef="mailto:redaction@cbip.be" Class="footer_link"><font color="#0000FF">redaction@cbip.be</font></A>
 - <A HRef="../Headertxt/Avertissement.htm" target="_blank" class="footer_link"><FONT Color="#0000FF">Avertissement / Disclaimer</FONT></A>
   </TD>
  </TR>
 </TABLE>

<script language="JavaScript" type="text/javascript" SRC="../JS/wz_tooltip.js"></script>
</BODY>
</HTML>
